|
Table of Contents |
| FDA Clears First Diagnostic Blood Test
for Congestive Heart Failure |
| FDA Clears Test to Detect Opiates in
Human Hair |
| FDA Clears Cyber-Care Blood Glucose
Monitoring System |
| New Test to Diagnose Neuromuscular
Conditions |
| New Immunoassay for Detection of
Osteoporosis |
| FDA Clears New Colorectal Test Designed
to Address Patient Noncompliance |
| FDA Clears New Prostate Specific Antigen
(PSA) Assays |
| Diasensor.com Launches Telemedicine
Service for Diabetics |
| FDA Approves New Noninvasive Device to
Monitor Glucose Levels |
| FDA Clears New Quantitative Allergy Blood
Test |
| FDA Clears Two New Test Kits to Diagnose
Cardiovascular Disorders |
| FDA Clears Automated Urine Drug Screening
Test |
| FDA Clears Diagnostic Test for
Osteoporosis |
| First Breath Test for Diabetes and
Insulin Resistance Receives Canadian Market
Approval |
| FDA Clears New Blood Glucose Monitoring
Test Strips |
| FDA Approves Two New Tests to Detect
Hepatitis C |
| FDA Clears New Breath Test for H.
Pylori |
| FDA Clears New Assay to Monitor Bladder
Cancer Recurrence |
| FDA Clears Rapid Capture System for
Detecting Chlamydia and Gonorrhoeae |
| FDA Approves Vitros Anti-HCV
Assay |
| Quest to Distribute Avitar’s Drugs of
Abuse Screen |
| FDA Clears Noninvasive Pediatric Blood
Pressure Monitor |
| FDA Clears Test for Detection of Cocaine
in Human Hair |
| FDA Clears Home Test for
Menopause |
| FDA Clears New Test to Detect
Ecstasy |
